| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
GDC-0941 |
FIMM |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0021 |
0.9 |